Clinical Investigative Site 6203 — Philadelphia, Pennsylvania

Clinical Investigative Site 6203 is a clinical research site located in Philadelphia, Pennsylvania, United States 19107.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Clinical Investigative Site 6203 has participated in 1 clinical trials.

Therapeutic areas: Asthma.

Sponsors: Idorsia Pharmaceuticals Ltd..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Clinical Investigative Site 6203?

Clinical Investigative Site 6203 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Clinical Investigative Site 6203 conducted?

Clinical Investigative Site 6203 has 1 clinical trials on record. Their work covers Asthma.

Is Clinical Investigative Site 6203 accredited by Crixeo Health?

Clinical Investigative Site 6203 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Clinical Investigative Site 6203?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.